Form 8.3 - Allergan plc


FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2007 (AS AMENDED)

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1) State Street Global Advisors & Affiliates
Company dealt in Allergan plc
Class of relevant security to which
the dealings being disclosed relate
(Note 2)
US$0.0001 ordinary shares
Date of dealing 18th Nov 2015

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

  Long Short
  Number (%) Number (%)
(1) Relevant securities 15,114,064 3.83474%    
(2) Derivatives (other than options) N/A      
(3) Options and agreements to
purchase/sell
N/A      
Total 15,114,064 3.83474%    

  Convertible Bonds Maturing 31 Dec 2049
  Number
Convertible Bond National 125,800
Total 125,800

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security: Long Short
  Number (%) Number (%)
(1) Relevant securities N/A      
(2) Derivatives (other than options) N/A      
(3) Options and agreements to purchase/sell N/A      
Total N/A      

3. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale Number of relevant securities Price per unit (Note 5)
Purchase  84 301.55
Purchase  2,600 309.80
Purchase  300 310.80
Purchase  300 310.80
Purchase  28,767 310.80
Purchase  6,072 310.80
Purchase  100 304.11
Purchase  100 308.32
Purchase  226 310.80
Purchase  129 310.80
Sale  28 307.84
Sale  506 310.80
Sale  300 310.80
Sale  100 309.74
Sale  300 310.80
Sale  15,500 310.80
Sale  2,208 310.80
Sale 17 310.80

 (b) Derivatives transactions (other than options transactions)

Product name,
e.g. CFD
Nature of transaction

(Note 6)
Number of relevant securities

(Note 7)
Price per unit

(Note 5)
N/A      

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,
e.g. call option
Writing, selling,
purchasing
 varying etc.
Number of
securities to which
the option relates
(Note 7)
Exercise
price
Type, e.g.
American,
European etc.
Expiry
date
Option money
paid/received
per unit
(Note 5)
N/A            

(ii) Exercising

Product name,
e.g. call option
Number of securities Exercise price per
unit
(Note 5)
N/A    

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction
(Note 8)
Details Price per unit
(if applicable)
(Note 5)
N/A    

4. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
N/A

Is a Supplemental Form 8 attached? (Note 9) NO


Date of disclosure 19th Nov 2015
Contact name Chetan Shah
Telephone number +(44) 20 3395 6564

 
If a connected EFM, name of offeree/offeror with which connected N/A
If a connected EFM, state nature of connection (Note 10) N/A
GlobeNewswire

Recommended Reading